Bioequivalence Study of Sumatriptan 100mg Tablets Under Fed Conditions
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
To access the single-dose oral bioequivalence of sumatriptan succinate 100 mg tablet
(containing 140 mg of sumatriptan succinate equivalent to 100 mg of sumatriptan) of OHM
Laboratories Inc. (a subsidiary of Ranbaxy Pharmaceutical Inc. USA) with IMITREX® 100 mg
tablet (containing 140 mg of sumatriptan succinate equivalent to 100 mg of sumatriptan) of
GlaxoSmithKline in healthy, adult, male, human subjects under fed condition.